Navigation Links
Cancer killing antibody effective against prostate cancer

Researchers at the University of California, Los Angles have taken a major step forward in the war against cancer by identifying the mechanism, which blocks off the development of prostate cancer in animals//.

The antibody that has been named 1G8 was discovered by UCLA scientists and according to Dr. Robert E. Reiter, a professor of urology and researcher at UCLA's Jonsson Cancer Center and the study's senior author it tells the cancer that it is time to die. The detailed report of the study is to be published in tomorrow's issue of Cancer Research, a peer- reviewed journal published by the American Association for Cancer Research.


'"/>




Page: 1

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
(Date:10/13/2008)...ation programs, along with referrals to cardiac re...ed rates of quitting smoking following heart attac...ue of Archives of Internal Medicine, one of the ...rchers studied 639 patients who smoked at the time...nths later, 297 of the patients approximately 47 ...
(Date:10/13/2008)...leep-wake system ,can,t remember anything, study ...) -- Your body clock may do more than help guide y...ital role in learning and memory, say Stanford Uni...they found that a functioning circadian system is ...they,ve learned. Without it, they "can,t remember ...
(Date:10/13/2008)...hargers Points to Myo-Med for Injury Recovery, PL...rs running-back,sensation LaDainian Tomlinson poin...o his recent injury rebound. In Sunday,s game agai... in NFL history to hit 11,000 career yards.,He car...y critics who,thought his early season injuries wo...
(Date:10/13/2008)...ts or service to new or existing customers., BOTH...iac Science,Corporation (Nasdaq: CSCX ) announced... field corrective action of certain automated exte...gust 2006 and March 2007. Some,AEDs manufactured i...rmance,doesn,t match the factory software settings...
Breaking Medicine News(10 mins):Health News:Circadian Rhythm Plays Role in Memory 2Health News:Tomlinson Attributes Rebound to Anti-Inflammatory Cream 2Health News:Cardiac Science Initiates Voluntary Field Corrective Action of Certain AEDs 2Health News:Cardiac Science Initiates Voluntary Field Corrective Action of Certain AEDs 3
...study conducted by the researchers down under stat...ood for lungs as well.// Vitamin d has been found ... for lungs and so offers great hope for smokers, a... respiratory problems. The researchers found peopl...
... all the ways genes that go the wrong way to cause...n decipher only part of the first page.// The U....US pilot project to unravel the genetic makeup of ...ng the discovery of gene culprits and treatments t...
...comprehensive study challenges the one accepted tr...ber-rich diet protects against colorectal cancer./...while those who consume food with high fibre conte... are somewhat less likely to get colon cancer, fib...
...ysician Committee for Responsible Medicine (PCRM) ...es test kit which measures the insulin level,// wh...ted to initiate the development of the test kit du...isms that it is not possible to develop the test k...
Other Medicine News:Health News:U.S. launching cancer gene-mapping pilot 2Health News:Study finds no link between fibre and cancer risk 2
(Date:10/10/2008)...t. 10 /- Diplomat Specialty,Pharmacy ...d Diplomat,Specialty Pharmacy to be one of only th...l Therapy Optimization Study for Multiple Sclerosi...dy, is to examine the benefits of a,specialty phar...erence and,patient outcomes. Targeted patient outc...
(Date:10/10/2008)... /- Inverness Medical,Innov...near-patient,diagnostics, monitoring and health ma..., the Secretary-General of the United Nations, as ...of the world,s leading,research-based and generic ..., together with senior officials from the United N...
(Date:10/10/2008).... 10 /- TriReme Medical Inc. (TMI),an... the CE (Conformite,Europeenne) marking and commer...ystem, a unique main vessel stent system specially...., Representing the next generation in bifurcatio...se in a quarter of the 2.2 million,angioplasty pro...
(Date:10/9/2008)...cuses on the need to protect the eyesight of,older...45 million people worldwide who,are blind, 80 perc...uld,have avoided their blindness if they had been ...media News Release, go to:, http://www.prnewswire....in eye care products and equipment, is,partnering ...
Breaking Medicine Technology:Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 2Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 3TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3Marteks lifesDHA 28TM 29 Featured in New Beech Nut 28R 29 DHA Plus Baby Food and Cereals 3856 1Marteks lifesDHA 28TM 29 Featured in New Beech Nut 28R 29 DHA Plus Baby Food and Cereals 3856 2Marteks lifesDHA 28TM 29 Featured in New Beech Nut 28R 29 DHA Plus Baby Food and Cereals 3856 3Ohio Delegation Members Urge Colleagues to Vote for Override of SCHIP Veto 3854 1Ohio Delegation Members Urge Colleagues to Vote for Override of SCHIP Veto 3854 2BioDiscovery Releases NEXUS CGH Version 2 for DNA Copy Number Analysis and Visualization 3852 1BioDiscovery Releases NEXUS CGH Version 2 for DNA Copy Number Analysis and Visualization 3852 2Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus 28R 29 Coronary Stent Systems at TCT 2007 538 1Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus 28R 29 Coronary Stent Systems at TCT 2007 538 2Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus 28R 29 Coronary Stent Systems at TCT 2007 538 3Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus 28R 29 Coronary Stent Systems at TCT 2007 538 4Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus 28R 29 Coronary Stent Systems at TCT 2007 538 5Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus 28R 29 Coronary Stent Systems at TCT 2007 538 6Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus 28R 29 Coronary Stent Systems at TCT 2007 538 7
...N, N.J., March 25, 2007 /PRNewswire/ -- Once-daily...ion tolvaptan, a,vasopressin receptor antagonist, ...toms of acutely decompensated heart failure (ADHF)...are, without an,adverse effect on their long-term ...e short- and long-term analyses of the,internation...
...ANS, March 26, 2007 /PRNewswire/ -- A large patien...Sirolimus-eluting,Coronary Stent reported favorabl...up, according to clinical investigators at the of,...7). , The MATRIX Registry is a prospective, single...rcutaneous coronary intervention (PCI,or balloon a...
Other Medicine Technology:Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 2Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 3Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 4Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 5Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 6Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 7Two-Year Patient Registry Results Support Safety and Efficacy of,Cypher Sirolimus-Eluting Coronary Stent in 'Real World' Uses 2Two-Year Patient Registry Results Support Safety and Efficacy of,Cypher Sirolimus-Eluting Coronary Stent in 'Real World' Uses 3Two-Year Patient Registry Results Support Safety and Efficacy of,Cypher Sirolimus-Eluting Coronary Stent in 'Real World' Uses 4
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: